References of "Krzesinski, Jean-Marie"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailConcepts actuels de l'hyperaldostéronisme primaire
Vroonen, Laurent ULg; Krzesinski, Jean-Marie ULg; Hamoir, Etienne ULg et al

in Revue Médicale de Liège (2010), 65(10), 583-587

Detailed reference viewed: 37 (14 ULg)
Full Text
Peer Reviewed
See detailUrinary NGAL: Use of absolute value or ratio to creatinine?
Cavalier, Etienne ULg; Bekaert, Anne-Catherine ULg; Legrand, Delphine ULg et al

in Acta Clinica Belgica (2010), 65-3

Introduction: Neutrophil gelatinase-associated lipocalin (NGAL) has emerged as a promising marker for the detection of acute kidney injury. This marker has been proposed for urinary measurement. However ... [more ▼]

Introduction: Neutrophil gelatinase-associated lipocalin (NGAL) has emerged as a promising marker for the detection of acute kidney injury. This marker has been proposed for urinary measurement. However, in the literature, authors indistinctly use "absolute" value or NGAL to creatinine ratio. Up to now, there are no strong arguments favouring for one. This question is of importance as this marker is sensed to be used only on urine random samples. To find an answer to this very practical matter, one approach could be to compare biological CV(intra-individual variation) of the "absolute" and ratio results. [less ▲]

Detailed reference viewed: 242 (0 ULg)
Full Text
Peer Reviewed
See detailUrinary or plasma NGAL?: Analytical point of view
Cavalier, Etienne ULg; Saarbach, D.; Bekaert, Anne-Catherine ULg et al

in Acta Clinica Belgica (2010)

Detailed reference viewed: 22 (2 ULg)
Full Text
Peer Reviewed
See detailÉpidémiologie de la maladie rénale chronique en République démocratique du Congo: une revue synthétique des études de Kinshasa, la capitale
Sumaili, E. K.; Krzesinski, Jean-Marie ULg; Cohen, E. P. et al

in Néphrologie & Thérapeutique (2010), 6

Chronic kidney disease (CKD) is a worldwide public health problem. Little is known about its burden in Africa. This paper reviews the knowledge of CKD in Kinshasa, summarizing four studies undertaken in ... [more ▼]

Chronic kidney disease (CKD) is a worldwide public health problem. Little is known about its burden in Africa. This paper reviews the knowledge of CKD in Kinshasa, summarizing four studies undertaken in the general population and traditional health system of Kinshasa. CKD was defined by either kidney damage (proteinuria 300 mg/day) or reduced kidney function (eGFR < 60 ml/min/1.73 m2). In the general population, the prevalence of CKD all stage is 12.4 %. Our work shows also the high prevalence of proteinuria among subjects who do not have diabetes or hypertension, the lack of early detection and management of CKD risk factors in the traditional health care system leading to late referral or premature deaths, and the limits of renal replacement treatment. CKD affects young people in the DRC, in contrast to the United States, where CKD is more prevalent in older people. Major determinants of CKD in our studies were hypertension, diabetes, overweight, age, lower socioeconomic status, and Human immunodeficiency virus (HIV) infection. Glomerular nephropathy (mainly focal segmental glomerulosclerosis) remains the leading cause of end stage renal disease. An annual screening of the population for proteinuria and CKD risk factors is feasible and will, it is hoped, provide the basis for building a nationwide prevention strategy. [less ▲]

Detailed reference viewed: 67 (12 ULg)
Full Text
Peer Reviewed
See detailEstimation of the Stability of Parathyroid Hormone when Stored at -80°C for a Long Period
Cavalier, Etienne ULg; Delanaye, Pierre ULg; Hubert, Philippe ULg et al

in Clinical Journal of the American Society of Nephrology (2009), 4(12), 1988-92

Detailed reference viewed: 50 (22 ULg)
See detailMise au point sur l'hypertension artérielle chez le sujet transplanté
Krzesinski, Jean-Marie ULg

Conference (2009, November 17)

Detailed reference viewed: 12 (6 ULg)
Full Text
Peer Reviewed
See detailAvancées concernant l’Aliskiren (Rasilez®), inhibiteur direct de la rénine, et l’Aliskiren-hydrochlorothiazide (Rasilez HCT ®)
Boxho, G.; Krzesinski, Jean-Marie ULg; Scheen, André ULg

in Revue Médicale de Liège (2009), 64(11), 560-565

Aliskiren (Rasilez®), a direct renin inhibitor, is currently indicated for the treatment of essential hypertension, as monotherapy or in combination, especially with hydrochlorothiazide (Rasilez HCT®). It ... [more ▼]

Aliskiren (Rasilez®), a direct renin inhibitor, is currently indicated for the treatment of essential hypertension, as monotherapy or in combination, especially with hydrochlorothiazide (Rasilez HCT®). It may also be use to obtain a more complete blockade of the renin-angiotensin-aldosterone system (RAAS) when it is associated with an angiotensin converting enzyme inhibitor (ACEI) (or an AT1 angiotensin receptor antagonist) (ARA). There is some room for agents that may be more efficacious in reducing the progression of diabetic nephropathy than ACEI or ARA. In this context, the dual blockade of RAAS most probably offers a better efficacy than the simple blockade, but also exposes to a higher risk. Should ongoing trials confirm the preliminary favourable results, aliskiren might reach a forefront position among the armamentarium now available to optimize the RAAS blockade. The present article will summarize advances concerning the biochemical effects of the specific mode of action of aliskiren, especially the potential interferences related to increased renin/pro-renin levels, as well as results of recent clinical trials, not only in hypertension, but also in the fields of diabetes, renal insufficiency and cardiology. The objectives and design of the landmark study ALTITUDE will also be briefly presented. [less ▲]

Detailed reference viewed: 162 (3 ULg)
Full Text
Peer Reviewed
See detailPulse pressure and pulse wave velocity as markers of arterial stiffness in patients with type 1 diabetes
Philips, Jean-Christophe ULg; Xhignesse, Patricia ULg; Marchand, Monique ULg et al

Conference (2009, October 19)

Type 1 diabetes was associated with an increase in both PP and PWV as compared to a nondiabetic population. In the diabetic population, a close correlation between the two indirect markers of arterial ... [more ▼]

Type 1 diabetes was associated with an increase in both PP and PWV as compared to a nondiabetic population. In the diabetic population, a close correlation between the two indirect markers of arterial stiffness was found and also between each of them and age (or diabetes duration), but not in controls. These observations support the concept of an earier arterial stiffness in type 1 diabetes with rather poor glycemic control. [less ▲]

Detailed reference viewed: 12 (1 ULg)
Full Text
Peer Reviewed
See detailPrevalence of Chronic Kidney Disease in an Elderly Population: Impact of the Choice of the Equation Used for Estimating GFR
Mariat, Christophe; Cavalier, Etienne ULg; Maillard, Nicolas et al

Poster (2009, October)

Detailed reference viewed: 17 (6 ULg)
See detailL'insuffisance rénale
Krzesinski, Jean-Marie ULg

Conference given outside the academic context (2009)

Detailed reference viewed: 5 (1 ULg)
See detailL'insuffisance rénale
Krzesinski, Jean-Marie ULg

Conference given outside the academic context (2009)

Detailed reference viewed: 11 (2 ULg)
See detailHypertension, prévention, traitements et conséquences
Krzesinski, Jean-Marie ULg

Conference (2009, September 22)

Detailed reference viewed: 10 (1 ULg)
Full Text
Peer Reviewed
See detailPulse pressure and ambulatory arterial stiffness index (AASI) in patients wit type 1 diabetes
Philips, Jean-Christophe ULg; Marchand, Monique ULg; Saint-Remy, Annie ULg et al

Conference (2009, September 19)

Results of PP and AASI measurements performed during a 24H AMBP recording and a 3 min posture test are not superimposable, but gave complementary information, in a population with type 1 diabetes mellitus ... [more ▼]

Results of PP and AASI measurements performed during a 24H AMBP recording and a 3 min posture test are not superimposable, but gave complementary information, in a population with type 1 diabetes mellitus. Our proof-of-concept study does not support the use of AASI as a cardiovascular risk marker when calculated during a short posture test. [less ▲]

Detailed reference viewed: 14 (0 ULg)